Literature DB >> 10903964

Mutational analysis of the interaction of the N- and C-terminal ends of angiotensin II with the rat AT(1A) receptor.

C M Costa-Neto1, A A Miyakawa, L Oliveira, S A Hjorth, T W Schwartz, A C Paiva.   

Abstract

1. The role of different residues of the rat AT(1A) receptor in the interaction with the N- and C-terminal ends of angiotensin II (AngII) was studied by determining ligand binding and production of inositol phosphates (IP) in COS-7 cells transiently expressing the following AT(1A) mutants: T88H, Y92H, G196I, G196W and D278E. 2. G196W and G196I retained significant binding and IP-production properties, indicating that bulky substituents in position 196 did not affect the interaction of AngII's C-terminal carboxyl with Lys(199) located three residues below. 3. Although the T88A mutation did not affect binding, the T88H mutant had greatly decreased affinity for AngII, suggesting that substitution of Thr(88) by His might hinder binding through an indirect effect. 4. The Y92H mutation caused loss of affinity for AngII that was much less pronounced than that reported for Y92A, indicating that His in that position can fulfil part of the requirements for binding. 5. Replacing Asp(278) by Glu caused a much smaller reduction in affinity than replacing it by Ala, indicating the importance of Asp's beta-carboxyl group for AngII binding. 6. Mutations in residues Thr(88), Tyr(92) and Asp(278) greatly reduced affinity for AngII but not for Sar(1) Leu(8)-AngII, suggesting unfavourable interactions between these residues and AngII's aspartic acid side-chain or N-terminal amino group, which might account for the proposed role of the N-terminal amino group of AngII in the agonist-induced desensitization (tachyphylaxis) of smooth muscles.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10903964      PMCID: PMC1572190          DOI: 10.1038/sj.bjp.0703430

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  21 in total

1.  Evidence for a regulatory site in the angiotensin II receptor of smooth muscle.

Authors:  M E Oshiro; S I Shimuta; T B Paiva; A C Paiva
Journal:  Eur J Pharmacol       Date:  1989-08-03       Impact factor: 4.432

2.  Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension.

Authors:  R M Horton; H D Hunt; S N Ho; J K Pullen; L R Pease
Journal:  Gene       Date:  1989-04-15       Impact factor: 3.688

Review 3.  Angiotensin II receptors and angiotensin II receptor antagonists.

Authors:  P B Timmermans; P C Wong; A T Chiu; W F Herblin; P Benfield; D J Carini; R J Lee; R R Wexler; J A Saye; R D Smith
Journal:  Pharmacol Rev       Date:  1993-06       Impact factor: 25.468

4.  Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor.

Authors:  T J Murphy; R W Alexander; K K Griendling; M S Runge; K E Bernstein
Journal:  Nature       Date:  1991-05-16       Impact factor: 49.962

5.  Chimeric NK1 (substance P)/NK3 (neurokinin B) receptors. Identification of domains determining the binding specificity of tachykinin agonists.

Authors:  U Gether; T E Johansen; T W Schwartz
Journal:  J Biol Chem       Date:  1993-04-15       Impact factor: 5.157

6.  Residues Val254, His256, and Phe259 of the angiotensin II AT1 receptor are not involved in ligand binding but participate in signal transduction.

Authors:  H M Han; S I Shimuta; C A Kanashiro; L Oliveira; S W Han; A C Paiva
Journal:  Mol Endocrinol       Date:  1998-06

7.  Tyr292 in the seventh transmembrane domain of the AT1A angiotensin II receptor is essential for its coupling to phospholipase C.

Authors:  J Marie; B Maigret; M P Joseph; R Larguier; S Nouet; C Lombard; J C Bonnafous
Journal:  J Biol Chem       Date:  1994-08-19       Impact factor: 5.157

8.  Biosynthesis of peptide precursors and protease inhibitors using new constitutive and inducible eukaryotic expression vectors.

Authors:  T E Johansen; M S Schøller; S Tolstoy; T W Schwartz
Journal:  FEBS Lett       Date:  1990-07-16       Impact factor: 4.124

9.  Changes in the levels of inositol phosphates after agonist-dependent hydrolysis of membrane phosphoinositides.

Authors:  M J Berridge; R M Dawson; C P Downes; J P Heslop; R F Irvine
Journal:  Biochem J       Date:  1983-05-15       Impact factor: 3.857

10.  Mutation of Asp74 of the rat angiotensin II receptor confers changes in antagonist affinities and abolishes G-protein coupling.

Authors:  C Bihoreau; C Monnot; E Davies; B Teutsch; K E Bernstein; P Corvol; E Clauser
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

View more
  2 in total

1.  Structure of the human angiotensin II type 1 (AT1) receptor bound to angiotensin II from multiple chemoselective photoprobe contacts reveals a unique peptide binding mode.

Authors:  Dany Fillion; Jérôme Cabana; Gaétan Guillemette; Richard Leduc; Pierre Lavigne; Emanuel Escher
Journal:  J Biol Chem       Date:  2013-02-05       Impact factor: 5.157

2.  Long range effect of mutations on specific conformational changes in the extracellular loop 2 of angiotensin II type 1 receptor.

Authors:  Hamiyet Unal; Rajaganapathi Jagannathan; Anushree Bhatnagar; Kalyan Tirupula; Russell Desnoyer; Sadashiva S Karnik
Journal:  J Biol Chem       Date:  2012-11-08       Impact factor: 5.157

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.